NCT06587009 Application of Shock Wave Technique in Conservative Treatment of Rotator Cuff Tear
| NCT ID | NCT06587009 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Rotator Cuff Tear |
| Study Type | INTERVENTIONAL |
| Enrollment | 22 participants |
| Start Date | 2024-05-05 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 22 participants in total. It began in 2024-05-05 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective cohort study and is a single-center clinical trial. Sample: This study will enroll about 22 patients from the Department of Sports Medicine and rehabilitation outpatient department of Beijing Third Hospital who are diagnosed with rotator cuff tear and choose conservative treatment.
Eligibility Criteria
Inclusion Criteria: * Identify patients with rotator cuff tears and choose conservative treatment * Able to complete cardiopulmonary exercise tests * Able to cooperate with rehabilitation training and complete questionnaire survey Exclusion Criteria: * Previous shoulder surgery history * Irreparable rotator cuff damage * Retear after ARCR
Contact & Investigator
Guoqing Cui
STUDY CHAIR
Peking University Third Hospital
Frequently Asked Questions
Who can join the NCT06587009 clinical trial?
This trial is open to participants of all sexes, aged 17 Years or older, up to 75 Years, studying Rotator Cuff Tear. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06587009 currently recruiting?
Yes, NCT06587009 is actively recruiting participants. Contact the research team at amilakuati@outlook.com for enrollment information.
Where is the NCT06587009 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06587009 clinical trial?
NCT06587009 is sponsored by Peking University Third Hospital. The principal investigator is Guoqing Cui at Peking University Third Hospital. The trial plans to enroll 22 participants.